Ketamine

Surgical and Diagnostic Procedures

Ketamine is used as a general anesthetic for short-term medical procedures. It works rapidly to produce a state of sedation and pain relief. Healthcare providers typically use it in the following ways:

• Induction of Anesthesia: It is often used to help a patient lose consciousness before other general anesthetic agents are administered.
• Sole Anesthetic: For certain minor or brief procedures, ketamine may be used on its own to provide both sedation and pain management.
• Supplement: It can be used in combination with other medications, such as nitrous oxide, to enhance the effects of anesthesia.

Emergency and Specialized Use

Ketamine is frequently utilized in emergency medicine and for procedures where muscle relaxation is not required. It is known as a dissociative anesthetic because it causes a patient to feel detached from their environment and pain while maintaining certain protective physical reflexes.

Other Clinical Applications

While its primary approved use is for anesthesia, ketamine is sometimes used in specialized clinical settings for the management of severe pain. Additionally, specific formulations or applications may be used under strict medical supervision for the treatment of certain mental health conditions, such as treatment-resistant depression, when other therapies have not been effective.

Dissociative Anesthesia

Ketamine works by inducing a state known as dissociative anesthesia. This is a trance-like condition where a person may feel detached from their environment and their own body. It achieves this by disrupting the communication pathways between the conscious mind and the parts of the brain that process sensory information, such as sight, sound, and pain.

NMDA Receptor Blockage

The primary mechanism of ketamine involves its interaction with the N-methyl-D-aspartate (NMDA) receptors in the brain and spinal cord. Ketamine acts as an antagonist, which means it binds to these receptors and blocks them. This action interferes with the activity of glutamate, a major chemical messenger (neurotransmitter) in the central nervous system.

Glutamate is responsible for several vital functions, including:

• Transmitting pain signals through the nervous system.
• Regulating how the brain perceives and responds to sensory input.
• Influencing learning and memory processes.

By blocking the NMDA receptors and altering glutamate activity, ketamine prevents the brain from processing pain signals normally. Unlike many other types of anesthesia, ketamine does not typically suppress the parts of the brain that control vital functions like breathing and blood circulation at standard medical doses.

Common Side Effects

• Nausea and vomiting
• Dizziness or drowsiness
• Blurred or double vision
• Loss of appetite
• Increased heart rate and blood pressure
• Increased salivation

Serious Side Effects

Seek medical attention immediately if you experience any of the following:

• Slow, shallow, or difficult breathing
• Chest pain or an irregular heartbeat
• Severe confusion, hallucinations, or irrational behavior
• Muscle stiffness or jerky, uncontrolled movements
• Signs of an allergic reaction, such as hives, skin rash, or swelling of the face, lips, or throat
• Painful urination, frequent urge to urinate, or blood in the urine

As the medication wears off, some individuals experience "emergence reactions." These may include vivid dreams, a feeling of detachment, or confusion. In a clinical setting, healthcare providers monitor patients closely to manage these psychological effects.

Psychological Effects

During recovery from anesthesia, some individuals experience emergence reactions. These reactions may include:

• Vivid dreams or nightmares
• Hallucinations
• Confusion or agitation
• Irrational behavior

These effects are generally less common in children and older adults. Medical providers may use other medications or minimize stimulation during the recovery period to help reduce these symptoms.

Cardiovascular and Respiratory Risks

Ketamine can cause significant increases in blood pressure and heart rate. It is typically avoided in patients where a rise in blood pressure would pose a serious health risk, such as those with severe cardiovascular disease or uncontrolled hypertension.

Respiratory depression or a temporary stop in breathing can occur, particularly if the medication is administered too quickly or in high doses. Continuous monitoring of heart and lung function by a healthcare professional is necessary during and after administration.

Bladder and Urinary Issues

Chronic or frequent use of ketamine, including compounded versions not approved by the FDA for specific conditions, has been linked to severe bladder problems. Symptoms may include frequent urination, pain during urination, and blood in the urine (cystitis).

Abuse and Dependence

Ketamine is a controlled substance with a potential for abuse and psychological dependence. Long-term use can lead to the development of tolerance and withdrawal symptoms if the medication is stopped abruptly.

Other Precautions

• Intracranial Pressure: Ketamine may increase pressure within the brain and should be used cautiously in patients with certain head injuries or brain conditions.
• Liver Function: Patients with liver impairment may require adjusted dosing or extra monitoring, as the drug is processed by the liver.
• Eye Pressure: Ketamine may increase pressure in the eyes and is used with caution in patients with glaucoma or eye injuries.
• Pregnancy: Safety during pregnancy has not been fully established, and use is generally avoided unless the medical necessity outweighs the potential risks.

Pregnancy

Ketamine is known to cross the placenta and reach the fetus. There is limited data from well-controlled studies regarding the use of ketamine in pregnant women. Animal studies have suggested that exposure to anesthetic and sedation drugs, including ketamine, during the third trimester of pregnancy may lead to adverse effects on brain development. Due to these potential risks, healthcare providers typically avoid using ketamine during pregnancy unless the medical necessity outweighs the potential risks to the fetus.

Labor and Delivery

When used during labor or for a cesarean section, ketamine may affect the newborn. High doses have been associated with respiratory depression and low muscle tone in infants at birth. Medical teams monitor both the mother and the baby closely if ketamine is administered during delivery.

Breastfeeding

It is not currently known if ketamine passes into human breast milk or what effects it may have on a nursing infant. Because the safety profile is not well-defined for breastfeeding, individuals should consult with their healthcare provider to discuss potential risks and benefits before using this medication.

Standard Medical Forms

Ketamine is primarily available as a sterile solution for injection. This liquid form is intended for administration by healthcare professionals in a controlled medical environment.

• Intravenous (IV) Administration: The solution is injected or infused directly into a vein.
• Intramuscular (IM) Administration: The solution is injected into a muscle.

Compounded Formulations

In some instances, pharmacies may create compounded versions of ketamine that are not FDA-approved. These formulations may include:

• Oral liquids or lozenges
• Nasal sprays

Regulatory agencies have cautioned that these compounded products have not been evaluated for safety, effectiveness, or quality in the same manner as the approved injectable form.

FDA Approval Status

Ketamine hydrochloride is FDA-approved as an injectable medication for the induction and maintenance of anesthesia. It is used for short diagnostic and surgical procedures that do not require skeletal muscle relaxation. It may be used as a sole anesthetic agent or as a supplement to other general anesthetic agents.

Compounded Ketamine Warnings

The FDA has issued safety communications regarding the use of compounded ketamine, which includes versions of the drug prepared by pharmacies in forms such as oral tablets, sublingual films, or nasal sprays. These compounded versions are not FDA-approved for any condition, including psychiatric disorders like depression, anxiety, or post-traumatic stress disorder (PTSD).

Key regulatory concerns identified by the FDA include:

• Lack of Evaluation: Compounded ketamine products have not undergone the FDA's rigorous review process for safety, effectiveness, or quality.
• Adverse Events: There are reported risks of serious side effects, including respiratory depression, increased blood pressure, and psychiatric events such as dissociation.
• Abuse Potential: As a Schedule III controlled substance, ketamine carries a risk of misuse and dependence. The FDA warns that using compounded products at home without medical supervision increases these risks.

Controlled Substance Status

Ketamine is regulated under the Controlled Substances Act as a Schedule III drug. This designation indicates that the medication has a currently accepted medical use in treatment in the United States but also has a potential for abuse that may lead to moderate or low physical dependence or high psychological dependence.

Potential for Abuse

Ketamine is classified as a Schedule III controlled substance, which means it has a recognized medical use but also carries a risk for misuse and dependence. It is sometimes used illicitly for its dissociative and hallucinogenic effects, often referred to as being in a "K-hole."

Tolerance and Dependence

Frequent or long-term use of ketamine can lead to several issues related to addiction:

• Tolerance: Users may find that they need increasingly larger doses to experience the same effects, which can lead to a cycle of escalating use.
• Psychological Dependence: Individuals may develop a strong emotional or mental drive to use the drug, experiencing cravings when it is not available.
• Withdrawal: While physical withdrawal is generally considered less severe than with some other substances, stopping chronic use can cause symptoms such as anxiety, sweating, and tremors.

To minimize the risk of addiction, ketamine must be administered by a healthcare professional in a controlled medical environment. It is not intended for unsupervised home use.